Showing results (451-460 of 516) with videos related to
Sort By:
Pageof 52
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.Nature Medicine|March 17, 2023
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncologyDominik Sturm, David Capper, Felipe Andreiuolo, et al.Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.Brain Pathology (Zurich, Switzerland)|July 4, 2014
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and gradingDavid N Louis, Arie Perry, Peter Burger, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.Acta Neuropathologica|November 17, 2019
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adultsChristian Thomas, Annika Wefers, Susanne Bens, et al.Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.Acta Neuropathologica|May 2, 2022
ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significanceAniello Federico, Christian Thomas, Katarzyna Miskiewicz, et al.Acta Neuropathologica|March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groupsMichael Weller, Ruthild G Weber, Edith Willscher, et al.Cancer Cell|May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialAlan Mackay, Anna Burford, Valeria Molinari, et al.Pageof 52